Improving FDA postmarket adverse event reporting for medical devices

被引：2
|
作者：
Wunnava, Susmitha [1 ,2 ]
Miller, Timothy A. [2 ,3 ]
Bourgeois, Florence T. [2 ,3 ]
机构：
[1] Harvard Med Sch, Harvard Mit Ctr Regulatory Sci, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA
来源：
BMJ EVIDENCE-BASED MEDICINE | 2023年 / 28卷 / 02期
关键词：
diagnosis; health care quality; access; and evaluation; policy; public health; therapeutics; DATABASE; UTILITY;
D O I：
10.1136/bmjebm-2021-111870
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [21] Improving adverse drug event reporting by healthcare professionals
    Shalviri, Gloria
    Mohebbi, Niayesh
    Mirbaha, Fariba
    Majdzadeh, Reza
    Yazdizadeh, Bahareh
    Gholami, Kheirollah
    Grobler, Liesl
    Rose, Christopher J.
    Chin, Weng Yee
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (10):
  • [22] Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
    Wen, Ming-Tao
    Li, Jia-Cheng
    Lu, Bo-Wen
    Shao, Hua-Rong
    Ling, Pei-Xue
    Liu, Fei
    Li, Gang
    Luo, Di
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [23] Signal detection of adverse reactions for bendamustine based on FDA adverse event reporting system
    Huang, Qing
    Wu, Yuanbin
    Li, Huimin
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (02) : 221 - 231
  • [24] Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system
    Byskov, Pernille Kahler
    Baden, Christoffer Storm
    Andersen, Jon Traerup
    Jimenez-Solem, Espen
    Olsen, Ramus Huan
    Gade, Christina
    Lausten-Thomsen, Ulrik
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [25] An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System
    Iyer, Geetha
    Marimuthu, Sathiya Priya
    Segal, Jodi B.
    Singh, Sonal
    DRUG SAFETY, 2017, 40 (09) : 799 - 808
  • [26] Data Mining of the Public Version of the FDA Adverse Event Reporting System
    Sakaeda, Toshiyuki
    Tamon, Akiko
    Kadoyama, Kaori
    Okuno, Yasushi
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (07): : 796 - 803
  • [27] An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System
    Geetha Iyer
    Sathiya Priya Marimuthu
    Jodi B. Segal
    Sonal Singh
    Drug Safety, 2017, 40 : 799 - 808
  • [28] A Decade of Nintedanib: An Analysis of the FDA Adverse Event Reporting System Database
    Niranjan, S.
    Rao, A.
    Virk, S. T.
    Sarangdhar, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [29] Indoor tanning injuries: an evaluation of FDA adverse event reporting data
    Dowdy, John C.
    Sayre, Robert M.
    Shepherd, James G.
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2009, 25 (04) : 216 - 220
  • [30] Association between GvHD and nivolumab in the FDA adverse event reporting system
    Y Oshima
    T Tanimoto
    K Yuji
    A Tojo
    Bone Marrow Transplantation, 2017, 52 : 1463 - 1464
12345